Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-01

Clinical Trial Update: Treximet Migraine Brain Imaging Research Study

View source ↗

Summary

The Treximet migraine brain imaging trial sponsored by McLean Hospital has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TREXIMET (sumatriptan succinate and naproxen sodium)

Snippet

Sponsor: Mclean Hospital | Conditions: Acute Migraine | Status: TERMINATED